Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8
Recruiting · NCT06487364 · Observational (researchers observe without assigning treatment) · Lead sponsor: Emre Şenocak
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.
Who can take part
Inclusion criteria
- Having regular neurology follow-up and using medicine;
- Hoehn and Yahr Scale Stage between 1-3 points;
- Mini-Mental State Assessment Score \>24 points;
Exclusion criteria
- Having a secondary neurological disease;
- Any surgery and/or trauma affecting the upper extremity
- Having complaints of pain before the treatment program;
- There was a change in medical treatment during the study;
- With symptoms of anxiety and depression;
- Those who use alcohol and drugs;
- Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss
Where it is running
1 location listed.
- Private Güney Hospital - Istanbul, Turkey (Türkiye)